loading...

Pediatric Oral Medicine Acceptability Questionnaire - Patient Version (P-OMAQ-P)

Sanofi Aventis

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • There are two versions of the P-OMAQ-P : one with a 24-hour recall period and one with a 7-day recall period.
  • The P-OMAQ-P has been simultaneously developed with the P-OMAQ Caregiver Version (P-OMAQ-C).
Authors

Sanofi Aventis

Copyright
POMAQ-P © Sanofi, 2018
Objective
To measure the acceptability of oral medicine formulations to pediatric patients
Therapeutic area
  • Generic
Therapeutic indication

All

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Diane M. Turner-Bowker, Kristina AnHaack, Meaghan Krohe, Andrew Yaworsky, Norma Vivas, Masami Kelly, Godhuli Chatterjee, Emily Chaston, Erin Mann and Matthew Reaney. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures. (submitted to HQLO)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Sanofi Aventis

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

POMAQ-P 24h

English for the UK

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust